HV-101 for Patients With Advanced Solid Tumors

Clinical trial NCT05868915 · TERMINATED

Trial details

NCT number: NCT05868915
Sponsor: Hervor Therapeutics
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2023-08-04
Primary completion: 2025-05-31
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.